Hematology analyzers are key tools used widely in patient and research settings to count and characterize blood cells for disease detection and monitoring. The latest report published by Decision Databases, extensively provides the global hematology analyzer market share, growth, trends and forecasts for the period 2015-2022. The report also calculates the market size in terms of revenue (USD MN) for the study period along with the details of the factors affecting the market growth (drivers and restraints).
The key factors that drive the market growth are -
- Growing prevalence of blood disorders
- Increasing geriatric population
However, the market growth might be restricted due to expensive instruments and lack of awareness under the study period.
The report divides the market into different segments based on products, reagents and end-users. Based on products, fully automated hematology analyzers and semi-automated analyzers are the two types of hematology analyzers. Other products include Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers and others. The reagents segment includes Coagulation Reagents, Flow Cytometery Reagents, Hematology Reagents, Control Plasmas, Hematology Stains and Immuno-Hematology Reagents.
End users include academics, hospitals, clinical testing institutes, biotech-pharmaceutical companies and patient self-testing. Based on region, North America (NA) tops the list followed by Europe (EU), Asia Pacific (APAC), Latin America (LA) and Middle East & Africa (MEA).
The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Beckman Coulter Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Mindray Medical International Ltd., Roche Diagnostics, Bio-Rad Laboratories, Drucker Diagnostics, Sigma Aldrich Corporation, Stago Group and Tcoag Ireland Ltd.